XML 44 R41.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Acquisition (Details Textual) (Cytometers [Member], USD $)
9 Months Ended
Jun. 30, 2011
Mar. 18, 2011
Cytometers [Member]
   
Acquisition (Textuals) [Abstract]    
Percentage of outstanding shares acquired   100.00%
Acquisition-date fair value of consideration transferred net of in cash acquired $ 204,970,000 $ 204,970,000
Cash acquired in acquisition   3,112,000
Research and development asset 42,300,000  
Goodwill in Biosciences segment 94,299,000  
Acquisition related costs in the current Period 900,000  
Portion of goodwill expected to be deductible for tax purposes $ 0